Fresenius Medical Care Stock Shares Owned By Insiders
FMS Stock | USD 22.71 0.03 0.13% |
Fresenius Medical Care fundamentals help investors to digest information that contributes to Fresenius Medical's financial success or failures. It also enables traders to predict the movement of Fresenius Stock. The fundamental analysis module provides a way to measure Fresenius Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fresenius Medical stock.
Fresenius | Shares Owned By Insiders |
Fresenius Medical Care Company Shares Owned By Insiders Analysis
Fresenius Medical's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Fresenius Shares Owned By Insiders Driver Correlations
Understanding the fundamental principles of building solid financial models for Fresenius Medical is extremely important. It helps to project a fair market value of Fresenius Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Fresenius Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Fresenius Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Fresenius Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition |
Based on the latest financial disclosure, 0.0% of Fresenius Medical Care are shares owned by insiders. This is 100.0% lower than that of the Health Care Providers & Services sector and about the same as Health Care (which currently averages 0.0) industry. The shares owned by insiders for all United States stocks is 100.0% higher than that of the company.
Fresenius Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresenius Medical's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fresenius Medical could also be used in its relative valuation, which is a method of valuing Fresenius Medical by comparing valuation metrics of similar companies.Fresenius Medical is currently under evaluation in shares owned by insiders category among its peers.
Fresenius Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Fresenius Medical from analyzing Fresenius Medical's financial statements. These drivers represent accounts that assess Fresenius Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Fresenius Medical's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 9.9B | 10.0B | 8.4B | 4.5B | 5.6B | 9.1B | |
Enterprise Value | 22.7B | 21.3B | 20.2B | 16.4B | 16.3B | 13.9B |
Fresenius Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Fresenius Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Fresenius Medical's managers, analysts, and investors.Environmental | Governance | Social |
Fresenius Fundamentals
Return On Equity | 0.0582 | ||||
Return On Asset | 0.0298 | ||||
Profit Margin | 0.03 % | ||||
Operating Margin | 0.08 % | ||||
Current Valuation | 24.36 B | ||||
Shares Outstanding | 586.83 M | ||||
Shares Owned By Institutions | 7.41 % | ||||
Number Of Shares Shorted | 852.45 K | ||||
Price To Earning | 6.53 X | ||||
Price To Book | 0.95 X | ||||
Price To Sales | 0.69 X | ||||
Revenue | 19.45 B | ||||
Gross Profit | 5.31 B | ||||
EBITDA | 3.21 B | ||||
Net Income | 732.46 M | ||||
Cash And Equivalents | 362.77 M | ||||
Cash Per Share | 1.75 X | ||||
Total Debt | 12.05 B | ||||
Debt To Equity | 0.88 % | ||||
Current Ratio | 1.18 X | ||||
Book Value Per Share | 46.43 X | ||||
Cash Flow From Operations | 2.63 B | ||||
Short Ratio | 3.11 X | ||||
Earnings Per Share | 1.17 X | ||||
Price To Earnings To Growth | 0.47 X | ||||
Target Price | 23.23 | ||||
Number Of Employees | 113.08 K | ||||
Beta | 0.85 | ||||
Market Capitalization | 13.34 B | ||||
Total Asset | 33.93 B | ||||
Retained Earnings | 10.92 B | ||||
Working Capital | 2.59 B | ||||
Current Asset | 6.98 B | ||||
Current Liabilities | 4.19 B | ||||
Annual Yield | 0.03 % | ||||
Five Year Return | 1.29 % | ||||
Net Asset | 33.93 B | ||||
Last Dividend Paid | 1.19 |
About Fresenius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresenius Medical Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius Medical Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.